Crispr Therapeutics Stock Forecast

Sell candidate since Jul 24, 2026

The CRISPR Therapeutics stock price fell by -2.08% on the last day (Friday, 24th Jul 2026) from $47.53 to $46.54. During the last trading day the stock fluctuated 4.48% from a day low at $46.01 to a day high of $48.07. The price has fallen in 7 of the last 10 days and is down by -12.76% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -389 thousand shares and in total, 1 million shares were bought and sold for approximately $61.60 million.

Given the current horizontal trend, you can expect CRISPR Therapeutics stock with a 90% probability to be traded between $46.52 and $61.85 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

CRSP Signals & Forecast

There are few to no technical positive signals at the moment. The CRISPR Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $47.54 and $52.78. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -24.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for CRISPR Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.06 between high and low, or 4.48%. For the last week, the stock has had daily average volatility of 3.57%.

CRISPR Therapeutics is oversold on RSI14 (12). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRSP) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect CRISPR Therapeutics AG to open at $46.87, and during the day (based on 14 day Average True Range), to move between $45.22 and $47.86, which gives a possible trading interval of +/-$2.64 (+/-5.83%) up or down from last closing price. If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 5.83% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $52.38, some $5.84 (12.55%) from the current price of $46.54, our system finds the risk reward not very attractive.

Is CRISPR Therapeutics AG stock A Buy?

CRISPR Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.981 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $46.87 ( 0.716%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk